Financhill
Back

Sarepta Therapeutics Vs. Hims & Hers Health Industry Stock Comparison

Sell
36

SRPT
Sarepta Therapeutics

Last Price:
114.48
Seasonality Move:
16.38%
Buy
82

HIMS
Hims & Hers Health

Last Price:
31.37
Seasonality Move:
21.12%
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $114.65. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
82
Hims & Hers Health (HIMS) is a Buy

Is Hims & Hers Health a Buy, Sell or Hold?

  • The current Hims & Hers Health [HIMS] share price is $31.35. The Score for HIMS is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
  • HIMS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $114.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

HIMS Stock Price Chart

What is Hims & Hers Health's stock price today?

  • The Hims & Hers Health share price today is $31.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HIMS is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.96 Sell
Relative Strength Index (14 RSI): 45.11 Sell
Chaikin Money Flow: 573405 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.03 - 128.71) Sell
Bollinger Bands (100): (119.2 - 142.7) Sell

HIMS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.46 Buy
Relative Strength Index (14 RSI): 66.48 Buy
Chaikin Money Flow: 48097363 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.97 - 25.87) Buy
Bollinger Bands (100): (15.86 - 22.8) Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.4 Buy
20-day SMA: 117.25 Sell
50-day SMA: 121.8 Sell
200-day SMA: 129.97 Sell
8-day EMA: 112.22 Buy
20-day EMA: 115.74 Sell
50-day EMA: 121.56 Sell
200-day EMA: 125.93 Sell

HIMS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.41 Buy
20-day SMA: 23.09 Buy
50-day SMA: 20.75 Buy
200-day SMA: 17.47 Buy
8-day EMA: 25.2 Buy
20-day EMA: 23.55 Buy
50-day EMA: 21.46 Buy
200-day EMA: 17.43 Buy

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.72 per share.

Hims & Hers Health Earnings Growth & HIMS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and an increase next year of $0.13 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Hims & Hers Health Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):